These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3299288)

  • 1. [Significance of the evaluation of C-peptide in children with type 1 diabetes mellitus].
    Gandullia E; Bonioli E; Monteverde R; La Fauci MF; Lattere M; Augeri C; De Grandi R; Chiossi M; Alpigiani MG
    Pediatr Med Chir; 1986; 8(5):687-9. PubMed ID: 3299288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Metabolic Outcomes in Children Diagnosed with Type 1 Diabetes Through Research Screening (Diabetes Autoimmunity Study in the Young [DAISY]) Versus in the Community.
    Chan CL; Taki I; Dong F; Hoffman M; Norris JM; Klingensmith G; Rewers MJ; Steck AK
    Diabetes Technol Ther; 2015 Sep; 17(9):649-56. PubMed ID: 26317880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-peptide in diabetes mellitus treated with insulin. A 3-year epidemiological study on the island of Falster, Denmark.
    Nielsen NV; Tronier B
    Diabetes Res; 1986 Nov; 3(9):475-8. PubMed ID: 3549123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes.
    Quattrin T; Haller MJ; Steck AK; Felner EI; Li Y; Xia Y; Leu JH; Zoka R; Hedrick JA; Rigby MR; Vercruysse F;
    N Engl J Med; 2020 Nov; 383(21):2007-2017. PubMed ID: 33207093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No effect of oral insulin on residual beta-cell function in recent-onset type I diabetes (the IMDIAB VII). IMDIAB Group.
    Pozzilli P; Pitocco D; Visalli N; Cavallo MG; Buzzetti R; Crinò A; Spera S; Suraci C; Multari G; Cervoni M; Manca Bitti ML; Matteoli MC; Marietti G; Ferrazzoli F; Cassone Faldetta MR; Giordano C; Sbriglia M; Sarugeri E; Ghirlanda G
    Diabetologia; 2000 Aug; 43(8):1000-4. PubMed ID: 10990077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Factors affecting C-peptide level during the first year of type 1 diabetes in children].
    Zmysłowska A; Szadkowska A; Andrzejewski W; Wegner O; Wyka K; Młynarski W; Bodalski J
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(2):103-11. PubMed ID: 15504313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of initial insulin dosage on blood glucose dynamics of children and adolescents with newly diagnosed type 1 diabetes mellitus.
    Wang Y; Gong C; Cao B; Meng X; Wei L; Wu D; Liang X; Li W; Liu M; Gu Y; Su C
    Pediatr Diabetes; 2017 May; 18(3):196-203. PubMed ID: 26947770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic factors affecting residual beta cell function assessed by C-peptide secretion in patients with newly diagnosed type 1 diabetes.
    Picardi A; Visalli N; Lauria A; Suraci C; Buzzetti R; Merola MK; Manfrini S; Guglielmi C; Gentilucci UV; Pitocco D; Crinò A; Bizzarri C; Cappa M; Pozzilli P
    Horm Metab Res; 2006 Oct; 38(10):668-72. PubMed ID: 17075776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-year prospective evaluation of the factors affecting honeymoon frequency and duration in children with insulin dependent diabetes mellitus: the key-role of age at diagnosis.
    Lombardo F; Valenzise M; Wasniewska M; Messina MF; Ruggeri C; Arrigo T; De Luca F
    Diabetes Nutr Metab; 2002 Aug; 15(4):246-51. PubMed ID: 12416662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic control in 131 juvenile-onset diabetic patients as measured by HbA1c: relation to age, duration, C-peptide, insulin dose, and one or two insulin injections.
    Dahlquist G; Blom L; Bolme P; Hagenfeldt L; Lindgren F; Persson B; Thalme B; Theorell M; Westin S
    Diabetes Care; 1982; 5(4):399-403. PubMed ID: 6759078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homogeneity in pattern of decline of beta-cell function in IDDM. Prospective study of 204 consecutive cases followed for 7.4 yr.
    Snorgaard O; Lassen LH; Binder C
    Diabetes Care; 1992 Aug; 15(8):1009-13. PubMed ID: 1505301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of the beta cell function in type I diabetes by the determination of peptide C after glucagon challenge].
    Alpigiani MG; Gandullia E; Lattere M; De Grandi R; Bonioli E
    Pediatr Med Chir; 1990; 12(3):239-41. PubMed ID: 2274434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twenty-four hour urinary C-peptide and fasting plasma C-peptide as indicators of metabolic control in 83 insulin dependent diabetic patients.
    Yoo HJ; Hartling SG; Binder C
    Korean J Intern Med; 1987 Jul; 2(2):196-200. PubMed ID: 3154831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors predicting residual beta-cell function in the first year after diagnosis of childhood type 1 diabetes.
    Couper JJ; Hudson I; Werther GA; Warne GL; Court JM; Harrison LC
    Diabetes Res Clin Pract; 1991 Jan; 11(1):9-16. PubMed ID: 2019237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proinsulin immunoreactivity in recent-onset IDDM: the significance of insulin antibodies and insulin autoantibodies.
    Snorgaard O; Kjems LL; Røder ME; Hartling SG; Dinesen B; Binder C
    Diabetes Care; 1996 Feb; 19(2):146-50. PubMed ID: 8718435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing the magnitude, duration, and rate of fall of B-cell function in type 1 (insulin-dependent) diabetic children followed for two years from their clinical diagnosis.
    Wallensteen M; Dahlquist G; Persson B; Landin-Olsson M; Lernmark A; Sundkvist G; Thalme B
    Diabetologia; 1988 Sep; 31(9):664-9. PubMed ID: 3069534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residual C-peptide production in type I diabetes mellitus. A comparison of different methods of assessment and influence on glucose control.
    Sjöberg S; Gunnarsson R; Ostman J
    Acta Med Scand; 1983; 214(3):231-7. PubMed ID: 6362338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial. Diabète Insuline Orale group.
    Chaillous L; Lefèvre H; Thivolet C; Boitard C; Lahlou N; Atlan-Gepner C; Bouhanick B; Mogenet A; Nicolino M; Carel JC; Lecomte P; Maréchaud R; Bougnères P; Charbonnel B; Saï P
    Lancet; 2000 Aug; 356(9229):545-9. PubMed ID: 10950231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Better HbA1c during the first years after diagnosis of type 1 diabetes is associated with residual C peptide 10 years later.
    Grönberg A; Espes D; Carlsson PO
    BMJ Open Diabetes Res Care; 2020 Feb; 8(1):. PubMed ID: 32107263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). The DCCT Research Group.
    J Clin Endocrinol Metab; 1987 Jul; 65(1):30-6. PubMed ID: 2884229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.